These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Phenomenological comparison of dextrose, lactate, and isoproterenol associated panic attacks. Balon R; Yeragani VK; Pohl R Psychiatry Res; 1988 Oct; 26(1):43-50. PubMed ID: 3070612 [TBL] [Abstract][Full Text] [Related]
8. Lactate and isoproterenol infusions in bulimic patients. Pohl R; Yeragani VK; Balon R; Lycaki H Neuropsychobiology; 1989; 22(4):225-30. PubMed ID: 2486382 [TBL] [Abstract][Full Text] [Related]
9. A comparison of lactate and isoproterenol anxiety states. Rainey JM; Pohl RB; Williams M; Knitter E; Freedman RR; Ettedgui E Psychopathology; 1984; 17 Suppl 1():74-82. PubMed ID: 6709798 [TBL] [Abstract][Full Text] [Related]
10. The relationship of panic disorder and its treatment outcome to 24-hour urinary MHPG levels. Garvey M; Noyes R; Cook B; Tollefson G Psychiatry Res; 1989 Oct; 30(1):53-61. PubMed ID: 2594871 [TBL] [Abstract][Full Text] [Related]
11. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Gurguis GN; Uhde TW Psychoneuroendocrinology; 1990; 15(3):217-24. PubMed ID: 2255749 [TBL] [Abstract][Full Text] [Related]
13. Plasma MHPG in untreated panic disorder. Edlund MJ; Swann AC; Davis CM Biol Psychiatry; 1987 Dec; 22(12):1491-5. PubMed ID: 3676379 [No Abstract] [Full Text] [Related]
14. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Charney DS; Heninger GR; Breier A Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977 [TBL] [Abstract][Full Text] [Related]